Intranasal esketamine plus oral antidepressant for treatment-resistant depression: acute induction and maintenance relapse-prevention outcomes in a systematic review and meta-analysis.
Authors: Xie J, Pu C, Sun M
Journal: Frontiers in psychiatry
psychopharmacology
mental health
open access